Cepheid's performance in the first quarter was driven by robust growth in clinical product sales resulting from test utilization in the emerging HAI test market for Xpert MRSA, continued adoption of ...

Cepheid has announced an agreement with VWR International to distribute Cepheid Industrial life science products in the United States. This non-exclusive agreement expands Cepheid's Industrial market ...

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases The two companies have completed a successful ...

Cepheid (Nasdaq: CPHD) and FIND (Foundation for Innovative New Diagnostics) today announced a new collaboration to accelerate the development of a rapid molecular test for the measurement of human ...

SUNNYVALE, Calif., Feb. 10, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that Warren Kocmond, formerly Executive Vice President and Chief Operating Officer, has been promoted to the ...

SUNNYVALE, Calif. (AP) -- Molecular diagnostics company Cepheid said Thursday it took a loss in the third quarter on costs related to a patent lawsuit. In late September Cepheid agreed to settle a ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...

On Jun 30, 2015, we issued an updated research report on California-based molecular diagnostics company CepheidCPHD, which develops, manufactures and markets fully integrated systems for clinical and ...

William R. Quirk – Piper Jaffray, Inc. Good day ladies and gentlemen and welcome to Cepheid’s Fourth Quarter and Fiscal Year 2012 earnings conference call. At this time, all participants are in a ...

Medical products maker Abaxis Inc. will get $17.25 million in a settlement with Cepheid Inc. Medical products maker Abaxis Inc. will get $17.25 million in a settlement with Cepheid Inc.

William Blair & Co. reiterated an "outperform" rating on Cepheid and said the company, which makes genetic analysis equipment, could see an increase in orders in the wake of the terrorist attacks in ...